INmune Bio CEO to present at Maxim Growth Summit on RDEB panel

Inmune Bio, Inc.

CEO David Moss will participate in a Dermatologic Rare Disease Panel at the Maxim Growth Summit on Oct 22, 2025.
Panel to discuss CORDStrom platform for Recessive Dystrophic Epidermolysis Bullosa (RDEB) treatment.
Summit takes place Oct 22-23 at Hard Rock Hotel, NYC; one-on-one meetings available.
No financial or operational updates provided in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.